Literature DB >> 2304743

Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups.

R Barone1, G Ficarra, D Gaglioti, A Orsi, F Mazzotta.   

Abstract

To study the prevalence of oral manifestations, we examined 217 patients infected with the human immunodeficiency virus (HIV). Most of our patients were intravenous drug abusers (IVDAs) (65%). Other risk categories were represented by IVDAs who were also male homosexuals or bisexuals (11%), male homosexuals and bisexuals (16%), sexual partners of HIV-infected patients (5%), and hemophilic persons and recipients of blood transfusions (3%). Forty-six patients were women and 171 were men, with a median age of 27 years (range, 11 to 65 years). At the time of first examination, 38% of patients had asymptomatic HIV infection, 36% had lymphadenopathy syndrome, 17% had AIDS-related complex, and 9% had AIDS. Oral manifestations were observed in 89 (41%) patients. Of these, 15 had asymptomatic infection, 23 had lymphadenopathy syndrome, 27 had AIDS-related complex, and 24 had AIDS. Increasing severity of disease was significantly associated with higher prevalence of oral lesions (p less than or equal to 0.0001). Candidiasis was the most common oral lesion, followed by hairy leukoplakia. Kaposi's sarcoma, melanotic macules, herpes labialis, condyloma acuminatum, perioral molluscum contagiosum, and bacterial glossitis due to Escherichia coli infection were found in a small number of patients. Results of culture for fungi, available for 203 patients, revealed that 51% of patients with positive Candida cultures had clinical evidence of candidiasis. Our study demonstrates that oral lesions are also important signs of HIV infection among IVDAs. Early diagnosis of these manifestations is becoming increasingly significant in the practice of dentistry.

Entities:  

Mesh:

Year:  1990        PMID: 2304743     DOI: 10.1016/0030-4220(90)90322-j

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  5 in total

1.  Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis.

Authors:  P Y Chavanet; I Garry; N Charlier; D Caillot; J P Kisterman; M D'Athis; H Portier
Journal:  BMJ       Date:  1992-10-17

2.  Toward improving the oral health of Americans: an overview of oral health status, resources, and care delivery. Oral Health Coordinating Committee, Public Health Service.

Authors: 
Journal:  Public Health Rep       Date:  1993 Nov-Dec       Impact factor: 2.792

3.  Oral manifestations of HIV.

Authors:  Smrati Bajpai; A R Pazare
Journal:  Contemp Clin Dent       Date:  2010-01

4.  Oral manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome and their correlation to cluster of differentiation lymphocyte count in population of North-East India in highly active antiretroviral therapy era.

Authors:  Sarat Kumar Nayak; Bijay Kumar Das; Surya Narayan Das; Namita Mohapatra; Suryakanti Nayak; Lipsa Bhuyan
Journal:  Contemp Clin Dent       Date:  2016 Oct-Dec

5.  Gender differences in oral lesions among persons with HIV disease in Southern India.

Authors:  Umadevi Krishna Mohan Rao; Kannan Ranganathan; Nagalingeswaran Kumarasamy
Journal:  J Oral Maxillofac Pathol       Date:  2012-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.